Vaccine mRNA, Plasmid DNA, and Spike Protein Can Persist in Humans More Than 3.5 Years After COVID-19 Vaccination
https://x.com/NicHulscher/status/2018442274883907874
BREAKING STUDY: Vaccine mRNA, Plasmid DNA, and Spike Protein Can Persist in Humans More Than 3.5 Years After COVID-19 Vaccination
We report the longest documented persistence of mRNA vaccine components to date, independently confirmed across multiple laboratories, biospecimens, and time points using diverse analytical methods.
For years, the public was told that mRNA vaccine materials would degrade within days to weeks — rapidly broken down, biologically transient, and incapable of long-term persistence. That assumption shaped regulatory assurances, public messaging, and safety expectations worldwide. Billions across the globe received these injections based on the claim that the genetic material would quickly disappear from the body.
Today, that narrative collapses — following a coordinated, multi-country investigative effort involving the McCullough Foundation, the INMODIA laboratory (Germany), the Municipal Hospital Dresden-Friedrichstadt (Germany), Neo7Bioscience, and collaborating independent laboratories.
The resulting paper, titled “Unprecedented Persistence of Vaccine mRNA, Plasmid DNA, Spike Protein, and Genomic Dysregulation Over 3.5 Years Post–COVID-19 mRNA Vaccination,” presents what is, to our knowledge, the most comprehensive COVID-19 vaccine injury case report to date.
A 55-year-old male developed progressive multi-organ dysfunction following three Pfizer mRNA doses, including pulmonary emboli, MRI-confirmed myocarditis, small fiber neuropathy, autonomic dysfunction, neurocognitive impairment, chronic GI involvement, sensorineural hearing loss, dermatologic inflammation, and anxiety/depression.
Diagnostic evaluation was extraordinary:
40+ ER visits
200+ specialist encounters (18 disciplines)
100+ lab investigations
100+ imaging/functional studies
Infectious, autoimmune, rheumatologic, endocrine, genetic, hematologic, malignant, toxic/medication-related, cardiovascular, metabolic, and primary neurologic causes were systematically excluded.
SARS-CoV-2 infection was effectively ruled out:
Nucleocapsid antibodies negative across 5 separate time points spanning 809–1,433 days post-vaccination, confirmed by 3 independent laboratories.
Nucleocapsid protein absent in serial skin biopsies obtained 1,160–1,364 days post-vaccination — despite clear spike protein deposition in the same specimens.
Meanwhile, spike antibodies remained persistently elevated, including 4,553 U/mL in January 2026 (1,433 days post-vaccination).
Serial blood & tissue sampling (852–1,364 days post-vaccination) revealed:
Day 852 — SARS-CoV-2 S1 protein detected within classical & non-classical monocyte subsets via blood-based immune phenotyping/flow cytometric analysis, with associated cytokine abnormalities.
Day 1,173 — Free Wuhan spike protein detected in plasma (129.0 ± 4.1 fg/mL) by high-sensitivity ELISA.
Day 1,173 — Spike protein detected in circulating exosomes (11.6 ± 0.1 fg/mL) by high-sensitivity ELISA following exosomal isolation.
Day 1,284 — Vaccine-derived spike mRNA detected in circulating exosomes by RT-PCR using DNase-treated RNA extraction and amplicon-specific primers targeting three spike ORF regions (S1–S3). PBMC RNA was negative.
Days 1,173 & 1,284 — Persistently elevated spike-specific IgG4 concentrations (354.4 ± 22.4 ng/mL; 320.2 ± 4.4 ng/mL) identified by serologic profiling, consistent with sustained antigen exposure.
Serial skin biopsies demonstrated:
Day 1,160 — Spike protein deposition in endothelial cells & macrophages detected by automated immunohistochemistry with histopathologic correlation; nucleocapsid protein absent.
Day 1,249 — Persistent spike protein deposition in endothelial and immune cell compartments by immunohistochemistry; nucleocapsid absent.
Day 1,364 — Spike protein detected in endothelial cells, macrophages, and nerve fibers by immunohistochemistry; nucleocapsid absent in the same specimen.
Day 1,364 — Plasmid DNA elements detected in skin tissue — including spike gene sequences (S1–S3), ori1/ori2, and SV40 enhancer fragments — confirmed by PCR amplification with agarose gel electrophoresis and Sanger sequencing.
Whole-genome sequencing structural variant analysis at 1,277 days post-vaccination revealed widespread genomic instability, with large duplications and deletions affecting EGFR, MYC, ERBB2, and ETV6/RUNX1, while RNA–DNA comparison showed RNA-only variants in ribosomal, NMD, small-RNA, epigenetic, and TP53 pathways.
Transcriptomic profiling of whole blood highlighted oxidative stress, vascular activation, and nuclear fragility.
Urine proteomics using quantitative mass spectrometry confirmed systemic inflammation with complement overactivation (CFH), redox imbalance (PRDX1), and sustained antibody responses, supported by risk alleles HLA-B07:02 and DRB1*11:04.
This longitudinal, multi-laboratory investigation provides direct evidence that mRNA vaccine–derived genetic material and its translated protein products can persist in humans for years following administration, with reproducible detection across multiple independent laboratories, distinct biological compartments, and complementary molecular detection systems extending beyond 3.5 years after the final dose.
Spike protein, spike mRNA sequences, and plasmid backbone elements were identified in both immune cells and somatic tissue, with continued absence of SARS-CoV-2 nucleocapsid protein or antibodies, effectively excluding prior infection as the source.
In parallel, multi-omic analyses revealed sustained genomic instability and transcriptomic dysregulation more than 3.5 years post-vaccination, suggesting that persistent vaccine-derived material may be associated with long-term alterations in host genomic and molecular pathways.
Yes, we were lied to.
posted by Satish Sharma at
11:13
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home